Part 2 of a 2-Part Sharsheret Webinar Series
Zoom Link Sent Upon Registration
Thursday, August 27, 2026 1pm ET/10am PT

The fear of recurrence is one of the most emotionally challenging aspects of cancer survivorship. That fear is often amplified around recurrence testing and scans. Recurrence risk tests like Prosigna, TrueMRD, Oncotype DX, MammaPrint, PreciseBreast, Foundation Medicine One MRD, and Signatera help our healthcare team gain vital understanding of each person's risk over time.
But waiting for the results can be distressing and even after results arrive, the fear of recurrence often lingers, shaping how we think, feel, and move through life after a diagnosis.
In Part 2 of our webinar series on risk of recurrence, Arash Asher, MD, will explore the psychosocial impact of living with recurrence risk: the anxiety of waiting, the weight of uncertainty, and strategies that can help you cope, find support, and reclaim a sense of control.
Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast cancer or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our expert and Bonnie Beckoff, Director of Sharsheret Support Services.
Questions? Contact Melanie Fisher at [email protected].
With support from:
Cooperative Agreement 24-0061 from the Centers for Disease Control and Prevention
Sponsors:
The Embrace Breakout Session is sponsored by:
*Disclaimer:



